Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

By Zuniga R.   Torcuator R.   Jain R.   Anderson J.   Doyle T.   Ellika S.   Schultz L.   Mikkelsen T.  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 329-336

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

By Komatsu Yoshito   Yuki Satoshi   Sogabe Susumu   Fukushima Hiraku   Nakatsumi Hiroshi   Kobayashi Yoshimitsu   Iwanaga Ichiro   Nakamura Michio   Hatanaka Kazuteru   Miyagishima Takuto   Kudo Mineo   Munakata Masaki   Meguro Takashi   Tateyama Miki   Sakata Yuh  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 867-872

Informa Healthcare

Access to resources Recommend Favorite

Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma - a new era in the treatment of malignant brain tumours?

By Henriksson Roger   Bergstrom Per   Johansson Mikael   Sandstrom Maria  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 6-8

Informa Healthcare

Access to resources Recommend Favorite

Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases

By Furuse Motomasa   Kawabata Shinji   Kuroiwa Toshihiko   Miyatake Shin-Ichi  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 471-475

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab Plus Irinotecan–Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens

By Yildiz Ramazan   Buyukberber Suleyman   Uner Aytug   Yamac Deniz   Coskun Ugur   Kaya Ali Osman   Ozturk Banu   Yaman Emel   Benekli Mustafa  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 33-37

Informa Healthcare

Access to resources Recommend Favorite